Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06261398 · ClinicalTrials.gov registry record · NA
Better Birth Outcomes Through Technology, Education, and Reporting
A NA study of Pregnancy and Preterm Birth, sponsored by Ohio State University.
- Recruiting
- Registry status
- NA
- Development phase
- 550
- Enrollment target
- 3
- Study locations
NCT06261398: Recruiting NA study of Pregnancy and Preterm Birth, sponsored by Ohio State University.
NCT06261398 is a NA study of Pregnancy and Preterm Birth that is actively recruiting participants, run by Ohio State University. The registered enrollment target is 550 participants, below the 870-participant average among 191 other Pregnancy trials with a reported enrollment target (37% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06261398, a NA study of Pregnancy and Preterm Birth, is actively recruiting participants, sponsored by Ohio State University.
- RECRUITING
- Registry status
- NA
- Development phase
- 550 participants
- Enrollment target
- 3
- Study locations
Study Summary
This is a pragmatic randomized control trial to evaluate the BETTER intervention compared to standard obstetrical care (control) to determine whether it helps to reduce maternal anemia and other adverse pregnancy outcomes. The BETTER intervention includes one motivational interviewing session and bi-weekly text messages to encourage patients to connect with resources that address their social needs, including housing, food, and transportation. Quantitative data will be used to study participant outcomes, including surveys, and electronic health record data.
Primary Outcome
Hemoglobin \< 11.0 g/dL
Conditions Studied
Interventions
- BEHAVIORAL Standard of care
- BEHAVIORAL BETTER: motivational interviewing and text messaging
Study Locations (3)
Ohio
- The Ohio State University Outpatient Care East - Columbus
- McCampbell Hall - Columbus
- The Ohio State University Wexner Medical Center OB/GYN Maternal and Fetal Medicine - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 550 participants |
| Start Date | 2024-02-26 |
| Est. Completion | 2028-03 |
| Phase | NA |
What NCT06261398 shows while recruiting
NCT06261398 is an interventional study that assigns participants to a tested intervention. The registered 550 participants enrollment target is mid-sized for trials with a published cap, below the 870-participant average among 191 other Pregnancy trials with a reported enrollment target (37% lower).
The record links to 4 conditions, with Pregnancy appearing as the primary indexed condition, and to 2 interventions - of which Standard of care is the first listed.
NCT06261398 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT06261398 about?
NCT06261398 is a clinical study titled "Better Birth Outcomes Through Technology, Education, and Reporting". This is a pragmatic randomized control trial to evaluate the BETTER intervention compared to standard obstetrical care (control) to determine whether it helps to reduce maternal anemia and other adverse pregnancy outcomes. The BETTER intervention includes one motivational interviewing session and bi...
What is the current status of trial NCT06261398?
This trial is currently recruiting. It is a NA study. The enrollment target is 550 participants. The study started on 2024-02-26. Estimated completion is 2028-03.
What conditions does trial NCT06261398 study?
This clinical trial studies the following conditions: Pregnancy, Preterm Birth, Maternal Anemia, Hypertensive Disorders.
What interventions are being tested in trial NCT06261398?
The interventions under investigation include: Standard of care (BEHAVIORAL), BETTER: motivational interviewing and text messaging (BEHAVIORAL).
Who is sponsoring clinical trial NCT06261398?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06261398 being conducted?
This trial has 3 study locations across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pregnancy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06261398's enrollment target sits among peer trials
550 45th of 191 higher than 146 of 191 other Pregnancy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pregnancy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
CGM Adherence Compared to Finger-stick Glucose Monitoring in Pregnancies With Type 2 Pregestational Diabetes
RECRUITING · NA
-
Cocooned Moms Study
RECRUITING · NA
-
CGM for Management of Type 2 Diabetes in Pregnancy
RECRUITING · NA
-
Feasibility of an ADAPTive Intervention to Improve Food Security and Maternal-Child Health
RECRUITING · NA
-
Enhancing Care & Outcomes for Patients During the First Postpartum Year
RECRUITING · NA
-
Mitigating Response to Stressors in Pregnant Women
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01852448 · 550 participants
Genetics of Insulin and Incretins in Cystic Fibrosis
- NCT02995252 · 550 participants
The HOPE Study: Characterizing Patients With Hepatitis B and C
- NCT03474913 · 550 participants
Upright MRI for Prostate Cancer Screening
- NCT04761120 · 550 participants
Annuloplasty Rings and Band Post-Market Clinical Follow-Up Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI